ResearcherKanazawa UniversityNo recent work listed

Masato Hioki

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070546573. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. Co-author DOI 10.1002/bdd.2131 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takuya Shimada · 1 shared paper, 2018 · strength 0.07
- Paper Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. DOI 10.1002/bdd.2131 ↗
Tetsuo Ohta · 1 shared paper, 2018 · strength 0.07
- Paper Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. DOI 10.1002/bdd.2131 ↗
Hidehiro Tajima · 1 shared paper, 2018 · strength 0.07
- Paper Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. DOI 10.1002/bdd.2131 ↗
Yoshimichi Sai · 1 shared paper, 2018 · strength 0.07
- Paper Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. DOI 10.1002/bdd.2131 ↗
Ikumi Tamai · 1 shared paper, 2018 · strength 0.07
- Paper Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. DOI 10.1002/bdd.2131 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.